C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/94 (2006.01) A61K 31/5377 (2006.01)
Patent
CA 2702297
The invention concerns certain crystalline solvates and hydrates of the compound of the Formula (I) (see formula I) which is known inter alia by way of the code number ZD1839. In particular, the invention concerns a first solvate that occurs in the presence of methanol which is designated as Form 2 ZD1839 MeOH solvate, a second solvate that occurs in the presence of dimethyl sulphoxide which is designated as Form 3 ZD1839 DMSO solvate and a trihydrate that occurs in the presence of water which is designated Form 5 ZD1839 trihydrate. The invention further concerns processes for the preparation of these solvates and the trihydrate and for their conversion back to the compound ZD1839, pharmaceutical compositions containing them and their use in the manufacture of medicaments for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.
Bohlin Martin
Gilday John Peter
Graham Anthony Stephen
Ymen Bo Ingvar
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Novel crystalline forms of the anti-cancer compound zd1839 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel crystalline forms of the anti-cancer compound zd1839, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel crystalline forms of the anti-cancer compound zd1839 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1781834